Vinpocetine
Vinca minor (source plant for vincamine)
A synthetic derivative of a periwinkle alkaloid, prescribed in parts of Europe and Asia for cerebrovascular disorders; sold as a nootropic in the US despite thin evidence, FDA warnings about its status, and a clear contraindication in pregnancy.
At a Glance
- Best known for
- Cerebral blood flow enhancement (demonstrated in imaging studies), Cognitive symptoms after stroke or in vascular dementia (low-quality trials), Tinnitus and inner-ear circulation (preliminary)
- Evidence
- Preliminary
- Typical dose
- 5–10 mg 3x daily
- Type
- Compound
What is Vinpocetine?
Vinpocetine is a man-made compound derived from vincamine, an alkaloid found in the leaves of the lesser periwinkle (Vinca minor). It was developed in Hungary in the late 1970s and is marketed there and in several other European and Asian countries as a prescription drug (Cavinton) for stroke recovery, vascular dementia, and inner-ear disorders. In the United States it has been sold as a dietary supplement and nootropic, but because it is a synthetic drug rather than a natural plant constituent, the FDA has stated it does not meet the legal definition of a dietary ingredient, and in 2019 the agency warned that it may cause miscarriage or harm fetal development. Its regulatory position therefore remains unsettled.
Known Health Benefits
How It Works
Vinpocetine has several overlapping actions. It inhibits phosphodiesterase type 1 (PDE1), raising cyclic GMP in vascular smooth muscle and dilating cerebral blood vessels, which increases blood flow to the brain without 'stealing' flow from other regions. It blocks voltage-gated sodium channels in neurons, reducing the excessive sodium and calcium influx that damages cells during low oxygen. It enhances glucose and oxygen uptake by brain tissue, reduces platelet aggregation and blood viscosity, and inhibits the IKK/NF-κB inflammatory pathway. Together these effects explain its use as a cerebral vasodilator and neuroprotectant, though human evidence for clinical benefit lags behind the mechanistic story.
What Research Says
Evidence for vinpocetine is weak despite decades of use. A 2003 Cochrane review on cognitive impairment and dementia found only three small trials (583 people total) and concluded there was insufficient evidence to support clinical use. Studies from the 1980s and 1990s, mostly from Hungary and Eastern Europe, reported improvements in memory, attention, and global function in people with chronic cerebrovascular disease, but they were short, small, and often poorly reported. Imaging studies have consistently shown increased cerebral blood flow and glucose uptake after vinpocetine, which supports the mechanism but not necessarily patient outcomes. A 2014 Chinese multicenter observational study of over 600 stroke patients reported modest functional benefit, but it was not placebo-controlled. One small trial in healthy volunteers found improved short-term memory at 40 mg, while another found no effect at lower doses. Small studies for tinnitus, Meniere's disease, and epilepsy adjunct therapy are inconclusive. Overall, vinpocetine shows pharmacological activity but has not been proven to improve cognition in any population through rigorous trials.
Active Compounds
Vinpocetine (ethyl apovincaminate), a semi-synthetic derivative of vincamine from lesser periwinkle; active metabolite apovincaminic acid
Forms & Bioavailability
Oral bioavailability is low and variable, roughly 7% on an empty stomach and 2–3 times higher when taken with food, so it should always be taken with meals. It is rapidly absorbed, peaks in blood within 1–2 hours, crosses the blood-brain barrier, and is cleared with a half-life of about 2–3 hours, which is why it is dosed three times daily. It is broken down largely to apovincaminic acid, which retains some activity. Extensive first-pass metabolism means individual blood levels can vary widely.
Dosage Guidance
| Use Case | Dosage |
|---|---|
| Chronic cerebrovascular insufficiency (prescription use abroad) | 5–10 mg 3x daily |
| Cognitive support (supplement use) | 5 mg 3x daily or 10 mg 2x daily |
| Tinnitus / inner ear (preliminary) | 10 mg 3x daily |
| Maximum studied dose | 20 mg 3x daily |
Always consult a healthcare provider for personalized dosing.
Potential Side Effects
Usually mild: flushing, headache, dizziness, nausea, dry mouth, nervousness, sleep disturbance, transient drop in blood pressure; rare skin rash
Who Should Avoid It
- Pregnancy or any possibility of pregnancy (FDA warning: miscarriage and fetal harm in animal studies)
- Breastfeeding
- Anticoagulant or antiplatelet therapy without monitoring (increased bleeding risk)
- Low blood pressure or recent fainting (hypotensive effect)
- Recent hemorrhagic stroke or intracranial bleeding
- Severe heart rhythm disorders, including long QT syndrome (reported QT effects at high doses)
Pregnancy & Lactation
Vinpocetine is contraindicated in pregnancy. Animal studies reviewed by the FDA found that doses comparable to human supplement doses decreased fetal weight and increased the chance of miscarriage, prompting a 2019 public warning advising pregnant women and women who could become pregnant not to use it. Because many supplement labels do not carry this warning and some products list it under the names 'Vinca minor extract,' 'lesser periwinkle extract,' or 'common periwinkle extract,' check ingredient lists carefully. It should also be avoided during breastfeeding due to lack of safety data.
Known Drug Interactions
May enhance anticoagulant and antiplatelet drugs (warfarin, aspirin, clopidogrel); additive hypotension with blood pressure medications; theoretical interaction with PDE inhibitors; may affect drugs metabolized by CYP3A4
Evidence Classification
Based on in vitro studies, animal models, pilot trials, or traditional use documentation. Clinical evidence is limited.
Frequently Asked Questions
Is vinpocetine a natural supplement?
Not really. Vinpocetine is a synthetic chemical made from vincamine, which does come from periwinkle, but vinpocetine itself does not exist in the plant. In Europe and Asia it is regulated as a prescription drug. The FDA has concluded it does not qualify as a dietary ingredient, which means its presence in US supplements exists in a legal gray zone that may change.
Does vinpocetine improve memory in healthy people?
The evidence is almost nonexistent — a single small older study found some benefit in short-term memory at a high dose, and others found none. The imaging data show it increases blood flow to the brain, which sounds appealing, but increased blood flow in a healthy brain does not automatically translate into better memory. Any effect in healthy adults should be regarded as unproven.
Why did the FDA issue a warning about vinpocetine?
In 2019 the FDA reviewed animal studies from the National Toxicology Program showing that vinpocetine reduced fetal weight and increased miscarriages in pregnant animals at doses similar to those used in supplements. Because many people taking nootropics are of reproductive age and product labels did not warn of this risk, the agency issued a public statement advising women who are pregnant or could become pregnant to avoid it.
How does vinpocetine compare to ginkgo?
Both are marketed as cerebral circulation enhancers. Ginkgo has a much larger body of research, including large trials (mostly showing no prevention of dementia but some symptom benefit), and a long safety record as a true plant extract. Vinpocetine has stronger measurable effects on blood flow but far less outcome data and more safety concerns, including the pregnancy warning and its uncertain regulatory status. For most people seeking a circulation-oriented cognitive supplement, ginkgo is the better-characterized option.
References
- Vinpocetine for cognitive impairment and dementia. Szatmari SZ, Whitehouse PJ. Cochrane Database of Systematic Reviews (2003)View study
- Statement on warning for women of childbearing age about possible safety risks of dietary supplements containing vinpocetine. U.S. Food and Drug Administration (2019)
- Vinpocetine. Examine.com (2023)View study
Related Health Conditions
Related Supplements
Have questions about Vinpocetine?
Ask Mother Nature AI about dosing, interactions with your medications, whether it fits your health goals, and more — personalized to your health profile.
This entry is for educational purposes only. It is not medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement regimen, especially if you take medications or have health conditions.